Novartis is presenting key advances in cancer research at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO; May 30-June 3, Chicago) and the 19th Congress of the European Hematology Association (EHA; June 12-15, Milan). Learn more about the diseases this research aims to treat, including chronic myeloid leukemia, myelofibrosis, breast cancer, kidney cancer and non-small cell lung cancer.
This animated infographic explains symptoms associated with myelofibrosis, a rare blood cancer, disease burden and unmet patient needs.
For more information, please visit www.novartis.com
Episode 4 of the Each Voice Counts talk show series, "The Experts," features advanced breast cancer experts Drs. Julie Gralow, Don Dizon and Adam Brufsky discussing treating patients with the disea...
Novartis is committed to supporting the kidney cancer community and continues to address the evolving needs of patients and caregivers. In this video, Dr. Sumanta Pal, Practicing Hematology/Oncolog...
This video is Chapter 1 of a two-part series highlighting significant medical advances in treating chronic myeloid leukemia (CML).